Genelux (GNLX) Times Interest Earned (2022 - 2026)
Genelux's (GNLX) quarterly Times Interest Earned came in at -$27.29 in Q1 2026, up 71.71% year-on-year from -$15.9 in Q1 2025, and down 22670.96% quarter-over-quarter from -$0.12 in Q4 2025.
Genelux (GNLX) Times Interest Earned (2022 - 2026) Analysis & Trends
Genelux's Times Interest Earned history runs 5 years deep, the most recent figure standing at -$27.29 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 71.71% year-over-year to -$27.29 in Q1 2026; TTM through Mar 2026 was -$102.88, a 164.88% decrease from a year earlier, with the FY2025 full-year figure at -$0.42, up 18.97% from the prior year.
- Times Interest Earned fell to -$27.29 in Q1 2026 per GNLX's latest filing, from -$0.12 in the prior quarter.
- Across five years, Times Interest Earned topped out at $162.84 in Q4 2022 and bottomed at -$96.49 in Q1 2025.
- The 5-year median for Times Interest Earned is -$1.1 (2025), against an average of $8.9.
- Biggest YoY gain for Times Interest Earned was 468.02% in 2024; the steepest drop was 57072.15% in 2024.
- Year by year, Times Interest Earned stood at $162.84 in 2022, then tumbled by 88.02% to $19.5 in 2023, then jumped by 468.02% to $110.77 in 2024, then sank by 100.11% to -$0.12 in 2025, then slumped by 22670.96% to -$27.29 in 2026.
- Per Business Quant, the three latest GNLX Times Interest Earned figures stand at -$27.29 (Q1 2026), -$0.12 (Q4 2025), and -$2.51 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | -27.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.29 |
| Dec 31, 2025 | -0.12 |
| Sep 30, 2025 | -2.51 |
| Jun 30, 2025 | -15.81 |
| Mar 31, 2025 | -96.49 |
| Dec 31, 2024 | 110.77 |
| Sep 30, 2024 | -41.32 |
| Mar 31, 2024 | -4.93 |
| Dec 31, 2023 | 19.50 |
| Sep 30, 2023 | -0.07 |
| Jun 30, 2023 | -0.05 |
| Mar 31, 2023 | -2.08 |
| Dec 31, 2022 | 162.84 |
| Sep 30, 2022 | 22.18 |